Some experts in the space see a big opportunity for Apple to help consumers pay their medical bills, which is a notoriously challenging process. » Read More
By: Nadine El-Bawab
For the first time the American Academy of Pediatrics and the American Heart Association endorsed enforcing taxes on sodas, among other precautions, in an effort to reduce children's consumption of sugary drinks. » Read More
The Food and Drug Administration approved a breakthrough medical device last week for patients suffering from chronic, hard-to-treat heart failure. » Read More
Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed. » Read More
The 'net price' for Eli Lilly's insulin fell to $135 a patient a month in 2018 from $147 in 2014, the company says.
Biogen said on Monday it would buy back shares worth $5 billion, days after its stock slumped on the drugmaker's announcement to end two Alzheimer's disease trials.
The nascent CBD industry is trying to work through the kinks at the same time demand is ramping up, leaving producers frustrated and consumers with unreliable products.
FDA chief Gottlieb leaves his post as the agency wages a pitched battle against teen smoking and tackles complex CBD regulations.
Doctors feel that taking metformin is mostly safe, but cautioned about the lack of clinical studies.
Biogen and Eisai lost billions of dollars in market value after halting two late-stage trials of a promising experimental Alzheimer's drug.
The maker of the premature ejaculation drug Promescent is suing consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade secrets.
The game theory comes in with the timing of when new rules might be adopted. Executives note the deadline for filing 2020 plans is in early June.
The news comes as the actor launched "SameYou", a charity aiming to offer treatment to those recovering from stroke and brain injury.
Former Aetna Chairman and CEO Mark Bertolini says investors currently are trading "on a basis that says, 'does this drug work today? Did this trial pass today?''"
To win big pharmaceutical advertisers, Snap is positioning itself as a friendlier social network than Facebook and Twitter.
Eisai said it has begun phase 3 clinical trials of Alzheimer's treatment, a day after the Japanese drugmaker and U.S. partner Biogen scrapped trials for its own Alzheimer's drug.
The study shows how sugar drives tumor growth, possibly explaining a surge in early colon cancer diagnoses in young adults.
Rite Aid shareholders have approved the company's reverse stock split, the company announced Thursday, a move aimed at keeping the drugstore chain's shares trading on New York Stock Exchange.
CVS has started selling CBD, short for cannabidiol products, in eight states. CEO Larry Merlo said CVS will "walk slowly."
Jim Cramer reveals why Nike is an ideal investment that can do well with or without a trade deal.